Stueland Katherine

US insider· US
Sign in for alerts
  • REDUCEDT+30

    GeneDx Holdings Corp · NASDAQ

    −148 sh · $14.1K

    Filed 18 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    GeneDx Holdings Corp · NASDAQ

    −4,141 sh · $406.9K

    Filed 18 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    GeneDx Holdings Corp · NASDAQ

    +18,750 sh

    Filed 18 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    GeneDx Holdings Corp · NASDAQ

    −1,648 sh · $155.3K

    Filed 18 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    GeneDx Holdings Corp · NASDAQ

    −3,039 sh · $300.8K

    Filed 18 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    GeneDx Holdings Corp · NASDAQ

    −1,525 sh · $147.8K

    Filed 18 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    GeneDx Holdings Corp · NASDAQ

    +6,547 sh

    Filed 11 Sept 2026SEC Form 4view source
  • REDUCEDStale

    GeneDx Holdings Corp · NASDAQ

    −3,692 sh · $310.9K

    Filed 11 Sept 2026SEC Form 4view source